vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Veritone, Inc. (VERI). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $26.6M, roughly 1.7× Veritone, Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -109.8%, a 89.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 21.1%). Veritone, Inc. produced more free cash flow last quarter ($-17.1M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 39.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Veritone, Inc. is an American artificial intelligence technology company based in Irvine, California founded in 2014. It serves a variety of industries including media, professional sports teams, federal government agencies, energy utilities, and state and local police departments.
ABCL vs VERI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $26.6M |
| Net Profit | $-8.9M | $-29.2M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | -68.2% |
| Net Margin | -19.9% | -109.8% |
| Revenue YoY | 788.4% | 21.1% |
| Net Profit YoY | 73.9% | -34.5% |
| EPS (diluted) | $-0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | — | ||
| Q3 25 | $9.0M | $26.6M | ||
| Q2 25 | $17.1M | $23.2M | ||
| Q1 25 | $4.2M | $22.5M | ||
| Q4 24 | $5.0M | $22.4M | ||
| Q3 24 | $6.5M | $22.0M | ||
| Q2 24 | $7.3M | $24.1M | ||
| Q1 24 | $10.0M | $24.2M |
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $-57.1M | $-29.2M | ||
| Q2 25 | $-34.7M | $-26.5M | ||
| Q1 25 | $-45.6M | $-19.9M | ||
| Q4 24 | — | $31.8M | ||
| Q3 24 | $-51.1M | $-21.7M | ||
| Q2 24 | $-36.9M | $-22.2M | ||
| Q1 24 | $-40.6M | $-25.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 72.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 71.2% | ||
| Q2 24 | — | 72.6% | ||
| Q1 24 | — | 70.8% |
| Q4 25 | -63.7% | — | ||
| Q3 25 | -851.8% | -68.2% | ||
| Q2 25 | -290.2% | -82.0% | ||
| Q1 25 | -1479.6% | -96.3% | ||
| Q4 24 | — | -93.8% | ||
| Q3 24 | -1439.4% | -102.3% | ||
| Q2 24 | -1276.2% | -84.4% | ||
| Q1 24 | -551.5% | -100.9% |
| Q4 25 | -19.9% | — | ||
| Q3 25 | -637.8% | -109.8% | ||
| Q2 25 | -203.3% | -114.2% | ||
| Q1 25 | -1077.2% | -88.5% | ||
| Q4 24 | — | 141.7% | ||
| Q3 24 | -785.4% | -98.9% | ||
| Q2 24 | -504.3% | -92.4% | ||
| Q1 24 | -408.0% | -104.3% |
| Q4 25 | $-0.03 | — | ||
| Q3 25 | $-0.19 | — | ||
| Q2 25 | $-0.12 | $-0.53 | ||
| Q1 25 | $-0.15 | $-0.41 | ||
| Q4 24 | — | $0.85 | ||
| Q3 24 | $-0.17 | $-0.57 | ||
| Q2 24 | $-0.13 | $-0.59 | ||
| Q1 24 | $-0.14 | $-0.67 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $36.2M |
| Total DebtLower is stronger | — | $35.4M |
| Stockholders' EquityBook value | $966.9M | $15.5M |
| Total Assets | $1.4B | $198.6M |
| Debt / EquityLower = less leverage | — | 2.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | $36.2M | ||
| Q2 25 | $92.4M | $13.6M | ||
| Q1 25 | $159.3M | $16.1M | ||
| Q4 24 | $156.3M | $16.9M | ||
| Q3 24 | $126.6M | $11.4M | ||
| Q2 24 | $148.3M | $46.0M | ||
| Q1 24 | $123.6M | $90.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | $35.4M | ||
| Q2 25 | — | $37.3M | ||
| Q1 25 | — | $39.2M | ||
| Q4 24 | — | $41.2M | ||
| Q3 24 | — | $73.6M | ||
| Q2 24 | — | $75.6M | ||
| Q1 24 | — | $77.5M |
| Q4 25 | $966.9M | — | ||
| Q3 25 | $964.0M | $15.5M | ||
| Q2 25 | $1.0B | $3.5M | ||
| Q1 25 | $1.0B | $14.8M | ||
| Q4 24 | $1.1B | $13.5M | ||
| Q3 24 | $1.1B | $-25.2M | ||
| Q2 24 | $1.1B | $-5.7M | ||
| Q1 24 | $1.1B | $14.9M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $198.6M | ||
| Q2 25 | $1.4B | $188.1M | ||
| Q1 25 | $1.3B | $199.6M | ||
| Q4 24 | $1.4B | $198.1M | ||
| Q3 24 | $1.4B | $336.4M | ||
| Q2 24 | $1.4B | $321.8M | ||
| Q1 24 | $1.5B | $359.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.28× | ||
| Q2 25 | — | 10.71× | ||
| Q1 25 | — | 2.66× | ||
| Q4 24 | — | 3.06× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.21× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-15.9M |
| Free Cash FlowOCF − Capex | $-44.6M | $-17.1M |
| FCF MarginFCF / Revenue | -99.4% | -64.2% |
| Capex IntensityCapex / Revenue | 21.9% | 4.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-46.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | — | ||
| Q3 25 | $-52.6M | $-15.9M | ||
| Q2 25 | $-32.4M | $-8.2M | ||
| Q1 25 | $-11.6M | $-17.0M | ||
| Q4 24 | $-108.6M | $-500.0K | ||
| Q3 24 | $-28.9M | $3.6M | ||
| Q2 24 | $-30.0M | $-42.7M | ||
| Q1 24 | $-41.7M | $14.9M |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | $-17.1M | ||
| Q2 25 | $-45.8M | $-9.2M | ||
| Q1 25 | $-22.2M | $-18.4M | ||
| Q4 24 | $-187.0M | $-1.7M | ||
| Q3 24 | $-47.4M | $1.9M | ||
| Q2 24 | $-50.1M | $-44.1M | ||
| Q1 24 | $-65.8M | $13.1M |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | -64.2% | ||
| Q2 25 | -267.9% | -39.6% | ||
| Q1 25 | -524.0% | -81.9% | ||
| Q4 24 | -3702.8% | -7.4% | ||
| Q3 24 | -728.4% | 8.6% | ||
| Q2 24 | -683.8% | -183.4% | ||
| Q1 24 | -661.5% | 54.2% |
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | 4.6% | ||
| Q2 25 | 78.2% | 4.1% | ||
| Q1 25 | 251.1% | 6.0% | ||
| Q4 24 | 1552.7% | 5.2% | ||
| Q3 24 | 284.6% | 7.7% | ||
| Q2 24 | 274.6% | 5.9% | ||
| Q1 24 | 242.5% | 7.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.02× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
VERI
| Software Products And Services | $20.9M | 78% |
| Other | $2.3M | 9% |
| Public Sector | $2.0M | 7% |
| Representation Services | $1.5M | 6% |
